Nipro Corp
TSE:8086

Watchlist Manager
Nipro Corp Logo
Nipro Corp
TSE:8086
Watchlist
Price: 1 481.5 JPY -1.04% Market Closed
Market Cap: 241.6B JPY
Have any thoughts about
Nipro Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one Nipro Corp stock under the Base Case scenario is 4 789.56 JPY. Compared to the current market price of 1 481.5 JPY, Nipro Corp is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 789.56 JPY
Undervaluation 69%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
46
vs Industry
83
Median 3Y
0.3
Median 5Y
0.4
Industry
2.3
Forward
0.4
More Details
184.9
P/E
P/E
Price to Earnings
184.9
vs History
4
vs Industry
29
Median 3Y
18.5
Median 5Y
14.6
Industry
23
Forward
14.6
More Details
3.5
P/OCF
P/OCF
Price to OCF
3.5
vs History
60
vs Industry
50
Median 3Y
3.5
Median 5Y
3.6
Industry
14.3
More Details
34.5
P/FCFE
P/FCFE
Price to FCFE
34.5
vs History
19
vs Industry
1
Median 3Y
-3.5
Median 5Y
-4.2
Industry
20
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
63
vs Industry
65
Median 3Y
0.9
Median 5Y
0.9
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
88
vs Industry
68
Median 3Y
1
Median 5Y
1.1
Industry
2.4
Forward
0.9
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
71
vs Industry
57
Median 3Y
3.4
Median 5Y
3.5
Industry
5
More Details
7.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.2
vs History
87
vs Industry
41
Median 3Y
7.5
Median 5Y
7.5
Industry
12.9
Forward
6.5
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
28
vs Industry
17
Median 3Y
26.8
Median 5Y
22.1
Industry
17.4
Forward
17.3
More Details
8.9
EV/OCF
EV/OCF
Enterprise Value to OCF
8.9
vs History
65
vs Industry
41
Median 3Y
8.9
Median 5Y
10.4
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-23.4
Industry
18.2
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
92
vs Industry
73
Median 3Y
0.6
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Nipro Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Nipro Corp
TSE:8086
241.6B JPY 0.4 184.9 7.2 27.6
JP
Hoya Corp
TSE:7741
6.8T JPY 8.3 34.8 22.9 27.6
CH
Alcon AG
SIX:ALC
37.8B CHF 4.3 36 17.7 34.3
DK
Coloplast A/S
CSE:COLO B
175.9B DKK 6.5 34.8 22.4 26.4
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 37 18.7 22.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY 11.8 28.2 24.5 24.5
KR
HLB Inc
KOSDAQ:028300
10.1T KRW 194.6 -54.4 -83.7 -79
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.5 11.9
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 55.9
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.1 266.5 465.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.6 23.2 38.1
P/E Multiple
Earnings Growth PEG
JP
Nipro Corp
TSE:8086
Average P/E: 50.5
184.9
22%
8.4
JP
Hoya Corp
TSE:7741
34.8
15%
2.3
CH
Alcon AG
SIX:ALC
36
27%
1.3
DK
Coloplast A/S
CSE:COLO B
34.8
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
37
26%
1.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.2
24%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -54.4 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.3
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.3 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.6
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Nipro Corp
TSE:8086
Average EV/EBITDA: 43
7.2
11%
0.7
JP
Hoya Corp
TSE:7741
22.9
15%
1.5
CH
Alcon AG
SIX:ALC
17.7
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.4
11%
2
US
Align Technology Inc
NASDAQ:ALGN
18.7
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
27%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -83.7 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
266.5
12%
22.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Nipro Corp
TSE:8086
Average EV/EBIT: 73.4
27.6
26%
1.1
JP
Hoya Corp
TSE:7741
27.6
N/A N/A
CH
Alcon AG
SIX:ALC
34.3
27%
1.3
DK
Coloplast A/S
CSE:COLO B
26.4
12%
2.2
US
Align Technology Inc
NASDAQ:ALGN
22.5
17%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
23%
1.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -79 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.9
12%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
55.9
56%
1
UK
ConvaTec Group PLC
LSE:CTEC
465.5
25%
18.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
38.1
36%
1.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 214,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.